The latest quarterly R&D expense is $38.14 Million with a QoQ Growth of +1.24%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $38.14M.
$38.14M
$38.14 Million
Q2 FY2026 · 2026-06-30
+1.24%
vs. $37.67M prior quarter
42
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $38.14M | +1.24% | +10.96% |
| Q1 FY2026Period end 2026-03-31 | $37.67M | +6.44% | +3.92% |
| Q4 FY2025Period end 2025-12-31 | $35.39M | -28.81% | -1.55% |
| Q3 FY2025Period end 2025-09-30 | $49.71M | +44.64% | +36.73% |
| Q2 FY2025Period end 2025-06-30 | $34.37M | -5.19% | -6.04% |
| Q1 FY2025Period end 2025-03-31 | $36.25M | +0.84% | +1.98% |
| Q4 FY2024Period end 2024-12-31 | $35.95M | -1.13% | -2.15% |
| Q3 FY2024Period end 2024-09-30 | $36.36M | -0.60% | +2.61% |
| Q2 FY2024Period end 2024-06-30 | $36.58M | +2.91% | -2.17% |
| Q1 FY2024Period end 2024-03-31 | $35.55M | -3.24% | -2.90% |
| Q4 FY2023Period end 2023-12-31 | $36.74M | +3.68% | +16.43% |
| Q3 FY2023Period end 2023-09-30 | $35.43M | -5.23% | +17.30% |
| Q2 FY2023Period end 2023-06-30 | $37.39M | +2.14% | +19.25% |
| Q1 FY2023Period end 2023-03-31 | $36.61M | +16.02% | +19.42% |
| Q4 FY2022Period end 2022-12-31 | $31.55M | +4.45% | +16.47% |
| Q3 FY2022Period end 2022-09-30 | $30.21M | -3.66% | +13.82% |
| Q2 FY2022Period end 2022-06-30 | $31.35M | +2.29% | +13.48% |
| Q1 FY2022Period end 2022-03-31 | $30.65M | +13.15% | +21.81% |
| Q4 FY2021Period end 2021-12-31 | $27.09M | +2.08% | +35.47% |
| Q3 FY2021Period end 2021-09-30 | $26.54M | -3.95% | +27.85% |
| Q2 FY2021Period end 2021-06-30 | $27.63M | +9.80% | +26.24% |
| Q1 FY2021Period end 2021-03-31 | $25.16M | +25.84% | +9.01% |
| Q4 FY2020Period end 2020-12-31 | $20.00M | -3.67% | +8.69% |
| Q3 FY2020Period end 2020-09-30 | $20.76M | -5.16% | +16.98% |
| Q2 FY2020Period end 2020-06-30 | $21.89M | -5.19% | +26.18% |
| Q1 FY2020Period end 2020-03-31 | $23.08M | +25.46% | +44.53% |
| Q4 FY2019Period end 2019-12-31 | $18.40M | +3.69% | +30.00% |
| Q3 FY2019Period end 2019-09-30 | $17.75M | +2.30% | +38.95% |
| Q2 FY2019Period end 2019-06-30 | $17.35M | +8.60% | +46.45% |
| Q1 FY2019Period end 2019-03-31 | $15.97M | +12.85% | +75.56% |
| Q4 FY2018Period end 2018-12-31 | $14.15M | +10.82% | +70.17% |
| Q3 FY2018Period end 2018-09-30 | $12.77M | +7.83% | +120.34% |
| Q2 FY2018Period end 2018-06-30 | $11.84M | +30.18% | +151.52% |
| Q1 FY2018Period end 2018-03-31 | $9.10M | +9.39% | +149.40% |
| Q4 FY2017Period end 2017-12-31 | $8.32M | +43.50% | +150.59% |
| Q3 FY2017Period end 2017-09-30 | $5.80M | +23.08% | +94.24% |
| Q2 FY2017Period end 2017-06-30 | $4.71M | +29.08% | +67.34% |
| Q1 FY2017Period end 2017-03-31 | $3.65M | +9.91% | N/A |
| Q4 FY2016Period end 2016-12-31 | $3.32M | +11.23% | N/A |
| Q3 FY2016Period end 2016-09-30 | $2.98M | +6.04% | N/A |
| Q2 FY2016Period end 2016-06-30 | $2.81M | N/A | N/A |
| Q1 FY2016Period end 2016-03-31 | $2.42M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
